We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-7.37%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$65.6B
AUM Growth
-$4.01B
Cap. Flow
+$2.13B
Cap. Flow %
3.25%
Top 10 Hldgs %
17.81%
Holding
764
New
62
Increased
390
Reduced
214
Closed
64

Top Sells

Rank Stock Value
1
OCR
OMNICARE INC
OCR
+$369M
2
EMC
EMC CORPORATION
EMC
+$356M
3
ALL icon
Allstate
ALL
+$332M
4
CVS icon
CVS Health
CVS
+$325M
5
TEL icon
TE Connectivity
TEL
+$268M

Sector Composition

Rank Sector Weight
1 Financials 26.35%
2 Healthcare 15.13%
3 Technology 14.24%
4 Industrials 12.69%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEO icon
251
The GEO Group
GEO
$4.13B
$28.4M 0.04%
1,432,854
+366,114
+34% +$8.09M
AMSG
252
DELISTED
Amsurg Corp
AMSG
$28.3M 0.04%
364,657
-69,617
-16% -$5.37M
GLDD
253
DELISTED
Great Lakes Dredge & Dock
GLDD
$27.9M 0.04%
5,539,110
+394,996
+8% +$2.17M
CYS
254
DELISTED
CYS Investments Inc.
CYS
$27.7M 0.04%
3,817,011
+66,908
+2% +$517K
GPI icon
255
Group 1 Automotive
GPI
$3.94B
$27.4M 0.04%
322,114
+5,865
+2% +$528K
RSTI
256
DELISTED
Rofin-Sinar Technologies Inc
RSTI
$26.9M 0.04%
1,037,802
+145,585
+16% +$3.69M
STNG icon
257
Scorpio Tankers
STNG
$3.96B
$26.7M 0.04%
290,915
+6,149
+2% +$616K
IART icon
258
Integra LifeSciences
IART
$1.54B
$25.9M 0.04%
870,246
-174,424
-17% -$5.45M
INTC icon
259
Intel
INTC
$466B
$25.5M 0.04%
845,369
+217,014
+35% +$6.28M
TGNA
260
DELISTED
TEGNA Inc
TGNA
$25.1M 0.04%
+1,751,780
New +$29.7M
LILAK icon
261
Liberty Latin America Class C
LILAK
$1.5B
$25M 0.04%
+852,807
New +$28.9M
MMS icon
262
Maximus
MMS
$3.14B
$24.6M 0.04%
412,775
+7,603
+2% +$483K
UVV icon
263
Universal Corp
UVV
$1.34B
$24.5M 0.04%
494,442
-11,788
-2% -$619K
TTEK icon
264
Tetra Tech
TTEK
$8.23B
$24.3M 0.04%
4,991,625
-51,600
-1% -$264K
MATW icon
265
Matthews International
MATW
$864M
$24.2M 0.04%
493,812
+25,728
+5% +$1.34M
MDRX
266
DELISTED
Veradigm Inc. Common Stock
MDRX
$24.2M 0.04%
1,948,210
-77,057
-4% -$1.06M
STGW icon
267
Stagwell
STGW
$1.84B
$24M 0.04%
1,304,090
+210,880
+19% +$3.95M
BDC icon
268
Belden
BDC
$4B
$23.9M 0.04%
511,395
+9,842
+2% +$580K
ISCA
269
DELISTED
International Speedway Corp
ISCA
$23.6M 0.04%
743,148
-86,554
-10% -$2.88M
ABM icon
270
ABM Industries
ABM
$2.8B
$23.5M 0.04%
858,885
+15,948
+2% +$504K
TPC
271
Tutor Perini Cor
TPC
$4.57B
$23.3M 0.04%
1,413,656
-12,942
-0.9% -$237K
CUBI icon
272
Customers Bancorp
CUBI
$2.59B
$23.2M 0.04%
903,850
+59,630
+7% +$1.52M
RPXC
273
DELISTED
RPX Corporation
RPXC
$23M 0.04%
1,679,031
+31,512
+2% +$467K
SGI
274
Somnigroup International
SGI
$15.1B
$23M 0.04%
1,289,312
-508,604
-28% -$9.34M
VIAB
275
DELISTED
Viacom Inc. Class B
VIAB
$22.4M 0.03%
520,081
-744,072
-59% -$36.9M

Similar funds

Boston Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Partners held 764 positions worth $65.6B, down 5.8% from $69.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners deployed $2.13B of net new capital in Q3 2015, opening 62 new positions and adding to 390 existing holdings. Its largest new stake was WestRock Company: 5,830,276 shares worth $270M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was EMC CORPORATION, an estimated $356M trimmed.

  • Boston Partners's largest Q3 2015 buy was WestRock Company: 5,830,276 shares worth $270M.
  • Boston Partners added most to Johnson & Johnson in Q3 2015, an estimated $282M increase.
  • Boston Partners's biggest Q3 2015 reduction was EMC CORPORATION, cutting an estimated $356M.
  • Boston Partners fully exited OMNICARE INC in Q3 2015, selling an estimated $369M.
  • Boston Partners's ten largest holdings make up 18% of its $65.6B portfolio in Q3 2015.
  • Boston Partners opened 62 new positions and closed 64 in Q3 2015.
  • Boston Partners's portfolio value fell 5.8% quarter-over-quarter to $65.6B.

Based on Boston Partners's 13F filing for Q3 2015, filed 10 Nov 2015.